Oshkosh Defense, an Oshkosh Corporation [NYSE: OSK] company, announced today it was awarded a contract from the U.S. Army to ...

FineHeart announced that it completed the $40.7 million first closing of its Series C financing round to support its heart failure treatment.

In 2006, Steve Pitkin suffered a serious heart attack while hiking above Salt Lake City with his daughter. The main artery in Pitkin’s heart was completely blocked, leaving 70% of his left ventricle ...

When it comes to receiving a new heart, some patients with advanced heart failure may be put at a disadvantage by recent policy changes from the US Centers for Medicare & Medicaid Services (CMS), ...

Duchenne Muscular Dystrophy may no longer be a death sentence. Oct. 17, 2012— -- Although he made it to 29 years old with Duchenne muscular dystrophy, Jason Williams was not expected to survive ...

New York, NY - Clinical outcomes for the sickest HF patients are far better among those given a left-ventricular assist device (LVAD) as compared with those maintained on inotropic drugs, whether they ...

Heart disease can leave a patient tied to a bed or a hospital room waiting on life, instead of living it. However, medical advances are giving people with heart disease a chance to live more freely - ...

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing tecarfarin, has announced a collaborative effort with Abbott (NYSE:ABT) to advance this novel anticoagulant for ...

Two years ago, on a family skiing trip to Colorado, Toby Wise was struggling to keep up. Wise, 45, had always been in good health, played football in high school and played in a softball league and a ...